Compare Humana Inc (HUM) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Visa Inc — how do they compare? Humana Inc trades at $374.95 (market cap $46.31B), while Visa Inc trades at $363.18 (market cap $668.96B). The key difference: Visa Inc is far larger — about 14.4× Humana Inc's market cap, and Humana Inc pays the higher dividend (0.92%). Which is the better fit depends on your goals.
| HUM | V | |
|---|---|---|
Market Cap | $46.31B | $668.96B |
Sector | Health | Financials |
52-Week High | $409.42 | $370.47 |
52-Week Low | $163.67 | $295.52 |
Enterprise Value | $53.67B | $679.54B |
Dividend Yield | 0.92% | 0.74% |
Volume | — | 10,431,336 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Visa (V) trades at $363.43, up 0.26% with strong fundamentals including 50.78% net income margin and consistent earnings beats. The stock shows bearish technical signals despite bullish moving averages, trading near resistance at $364. Recent developments include AI commerce initiatives and stablecoin partnerships positioning Visa for future growth. Revenue grew to $40B in 2025 with robust cash flow generation of $23.06B from operations.
Visa presents a compelling long-term investment with 85% analyst buy ratings and $426.31 price target (17% upside). Risks include fintech disruption and regulatory pressures, but the company's dominant payment network, AI integration, and stable financials support continued growth. The upcoming Q3 2026 earnings on April 28 will be a key catalyst.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
